Search Results

[Webinar] The Strategies of NK Cell Related IO Therapy in Preclinical Drug Evaluation (20220726 2nd)

[Webinar] The Strategies of NK Cell Related IO Therapy in Preclinical Drug Evaluation (20220726 2nd)

The Bench to Bedside Series: Preclinical Cancer Research with Scintica

The Bench to Bedside Series: Preclinical Cancer Research with Scintica

How to Evaluate Preclinical and Clinical DILI

How to Evaluate Preclinical and Clinical DILI

Cancer Discovery and Preclinical Validation Using Patient-Derived Xenografts

Cancer Discovery and Preclinical Validation Using Patient-Derived Xenografts

The advantages of patient-derived using xenograft models for preclinical oncology research

The advantages of patient-derived using xenograft models for preclinical oncology research

[Webinar] Protein O-GlcNAcylation: a sweet “weep & sweep” for helminth expulsion (20220830 1st)

[Webinar] Protein O-GlcNAcylation: a sweet “weep & sweep” for helminth expulsion (20220830 1st)

ESCMID/ASM Conference 2022 Bootcamp 2 : Discovery and preclinical development challenges

ESCMID/ASM Conference 2022 Bootcamp 2 : Discovery and preclinical development challenges

Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies

Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies

Lost in translation: learning from preclinical data | Gerry Davies

Lost in translation: learning from preclinical data | Gerry Davies

ACTRIS Cell Therapy Lecture: Joint Preservation: Cells or Exosomes?

ACTRIS Cell Therapy Lecture: Joint Preservation: Cells or Exosomes?

TRANSLATING FROM TARGET TO CLINICAL TRIAL: WHAT YOU NEED TO KNOW ABOUT PRECLINICAL STUDIES

TRANSLATING FROM TARGET TO CLINICAL TRIAL: WHAT YOU NEED TO KNOW ABOUT PRECLINICAL STUDIES

[NUVISAN Talk] How to Translate Your Oncology Target into a Preclinical Candidate - Part 2

[NUVISAN Talk] How to Translate Your Oncology Target into a Preclinical Candidate - Part 2